Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis S Singh, KK Roy, SR Khan, VK Kashyap, A Sharma, S Jaiswal, ... Bioorganic & Medicinal Chemistry 23 (4), 742-752, 2015 | 72 | 2015 |
Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus H Shukla, V Kumar, AK Singh, S Rastogi, SR Khan, MI Siddiqi, ... International journal of biological macromolecules 78, 137-141, 2015 | 45 | 2015 |
Biological evaluation of novel substituted chloroquinolines targeting mycobacterial ATP synthase SR Khan, S Singh, KK Roy, MS Akhtar, AK Saxena, MY Krishnan International journal of antimicrobial agents 41 (1), 41-46, 2013 | 43 | 2013 |
Mycobacterium tuberculosis persistence in various adipose depots of infected mice and the effect of anti-tubercular therapy P Agarwal, SR Khan, SC Verma, M Beg, K Singh, K Mitra, AN Gaikwad, ... Microbes and Infection 16 (7), 571-580, 2014 | 37 | 2014 |
Synthesis and anti-tubercular activity of conformationally-constrained and bisquinoline analogs of TMC207 D Kalia, AK KS, G Meena, KP Sethi, R Sharma, P Trivedi, SR Khan, ... MedChemComm 6 (8), 1554-1563, 2015 | 21 | 2015 |
Alternate pathway to ascorbate induced inhibition of Mycobacterium tuberculosis H Shukla, SR Khan, R Shukla, MY Krishnan, MS Akhtar, T Tripathi Tuberculosis 111, 161-169, 2018 | 16 | 2018 |
Effect of various drugs on differentially detectable persisters of Mycobacterium tuberculosis generated by long-term lipid diet SR Khan, U Venugopal, G Chandra, S Bharti, RK Maurya, MY Krishnan Tuberculosis 115, 89-95, 2019 | 9 | 2019 |
Viscometric behaviour and micellar studies of Cu (II) surfactant derived from Neem (AzadirectaIndica)) oil in methanol-benzene mixture at 298. 15 K AK Sharma, S Khan, R Sharma Global J. Eng. Sci. Res 5, 9-16, 2018 | 7 | 2018 |
Health aspects of traditionally processed indigenous edible oils R Sharma, S Khan Recent Progress in Medicinal Plants, Natural Products-II 18, 430, 2007 | 6 | 2007 |
Coupling reporter expression to respiration detects active as well as dormant mycobacteria in vitro and in mouse tissues SC Verma, U Venugopal, SR Khan, MS Akhtar, MY Krishnan International Journal of Mycobacteriology 3 (1), 25-35, 2014 | 3 | 2014 |
Discovery of a New Antibiotic Demethoxytetronasin Using a Dual-Sided Agar Plate Assay (DAPA) JH Lee, R Ma, L Nguyen, S Khan, M Qader, E Mpofu, G Shetye, NK Krull, ... ACS Infectious Diseases 9 (8), 1593-1601, 2023 | 2 | 2023 |
Rv0100: An essential acyl carrier protein from M. tuberculosis important in dormancy HJ Gutka, JMG Bondoc, R Patwell, S Khan, EM Grzelak, R Goswami, ... Plos one 19 (6), e0304876, 2024 | | 2024 |
Alternate pathway to ascorbate induced inhibition of Mycobacterium tuberculosis. HS Harish Shukla, SR Khan, RS Rohit Shukla, MY Krishnan, MS Akhtar, ... | | 2018 |
Akhtar2*, Timir Tripathi1 H Shukla, SR Khan, R Shukla, MY Krishnan, M Sohail | | 2017 |
Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis … S Singh, KK Roy, SR Khan, VK Kashyap, A Sharma, S Jaiswal, ... BIOORGANIC & MEDICINAL CHEMISTRY 23 (13), 3871-3871, 2015 | | 2015 |
Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus. HS Harish Shukla, VK Vikash Kumar, AK Singh, SR Shivangi Rastogi, ... | | 2015 |
Corrigendum to “Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M … S Singh, KK Roy, SR Khan, VK Kashyap, A Sharma, S Jaiswal, ... Bioorganic & Medicinal Chemistry 13 (23), 3871, 2015 | | 2015 |
Mycobacterium tuberculosis persistence in various adipose depots of infected mice and the effect of anti-tubercular therapy SR Khan, SC Verma, M Beg, K Singh, K Mitra, AN Gaikwad, S Akhtar, ... Microbes and Infection 20, 1e10, 2014 | | 2014 |
N-(3-((diethylamino) methyl)-4-hydroxyphenyl)-n-(quinolin-4-yl) sulfonamides for the treatment of tuberculosis and process of preparation thereof AKS Supriya SINGH, Kuldeep Kumar ROY, Shaheb Raj KHAN, Vivek Kumar KASHYAP ... | | 2013 |
MedChemComm G Meena, KP Sethi, R Sharma, P Trivedi, SR Khan, AS Verma, S Singh, ... | | |